Research ArticleArticle
Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis
Carolina Birolo, Maria Elisabetta Zannin, Svetlana Arsenyeva, Rolando Cimaz, Elisabetta Miserocchi, Margarita Dubko, Chantal Job Deslandre, Fernanda Falcini, Maria Alessio, Francesco La Torre, Ekaterina Denisova, Giorgia Martini, Irina Nikishina and Francesco Zulian
The Journal of Rheumatology November 2016, 43 (11) 2068-2073; DOI: https://doi.org/10.3899/jrheum.151389
Carolina Birolo
From the Department of Pediatrics, Rheumatology Unit, University of Padua, Padua,
Italy; Scientific Research Institute of Rheumatology RAMS, Moscow,
Russian Federation; A. Meyer Children’s Hospital, Rheumatology Unit, and Department of Internal Medicine, Section of Rheumatology, University of Florence, Florence,
Italy; Department of Ophthalmology, Scientific Institute San Raffaele, Milan,
Italy; Saint-Petersburg Pediatric Medical Academy, Saint-Petersburg,
Russian Federation; Rheumatology Service, Cochin Hospital, Paris,
France; Department of Pediatrics, Rheumatology Unit, University of Naples Federico II, Naples,
Italy; Department of Pediatrics, Antonio Perrino Hospital, Brindisi,
Italy; Helmgoltz Moscow Research Institute of Eye Diseases, Moscow,
Russian Federation.
Maria Elisabetta Zannin
Svetlana Arsenyeva
Rolando Cimaz
Elisabetta Miserocchi
Margarita Dubko
Chantal Job Deslandre
Fernanda Falcini
Maria Alessio
Francesco La Torre
Ekaterina Denisova
Giorgia Martini
Irina Nikishina
Francesco Zulian
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- Tynjälä P,
- Lindahl P,
- Honkanen V,
- Lahdenne P,
- Kotaniemi K
- 4.↵
- Zannin ME,
- Martini G,
- Buscain I,
- Cermàkovà I,
- Manara R,
- Zulian F
- 5.↵
- Zannin ME,
- Birolo C,
- Gerloni VM,
- Miserocchi E,
- Pontikaki I,
- Paroli MP,
- et al.
- 6.↵
- 7.↵
- 8.↵
- Yamada A,
- Salama AD,
- Sayegh MH
- 9.↵
- 10.↵
- 11.↵
- 12.↵
- Simonini G,
- Zannin ME,
- Caputo R,
- Falcini F,
- de Martino M,
- Zulian F
- 13.↵
- 14.↵
- 15.↵
- Angeles-Han S,
- Flynn T,
- Lehman T
- 16.↵
- Elhai M,
- Deslandre CJ,
- Kahan A
- 17.↵
- 18.↵
- 19.↵
- 20.↵
- Tappeiner C,
- Miserocchi E,
- Bodaghi B,
- Kotaniemi K,
- Mackensen F,
- Gerloni V,
- et al.
- 21.↵
- 22.↵
- Genant HK,
- Peterfy CG,
- Westhovens R,
- Becker JC,
- Aranda R,
- Vratsanos G,
- et al.
- 23.↵
- 24.↵
- Simonini G,
- Taddio A,
- Cattalini M,
- Caputo R,
- de Libero C,
- Parentin F,
- et al.
In this issue
The Journal of Rheumatology
Vol. 43, Issue 11
1 Nov 2016
Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis
Carolina Birolo, Maria Elisabetta Zannin, Svetlana Arsenyeva, Rolando Cimaz, Elisabetta Miserocchi, Margarita Dubko, Chantal Job Deslandre, Fernanda Falcini, Maria Alessio, Francesco La Torre, Ekaterina Denisova, Giorgia Martini, Irina Nikishina, Francesco Zulian
The Journal of Rheumatology Nov 2016, 43 (11) 2068-2073; DOI: 10.3899/jrheum.151389
Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis
Carolina Birolo, Maria Elisabetta Zannin, Svetlana Arsenyeva, Rolando Cimaz, Elisabetta Miserocchi, Margarita Dubko, Chantal Job Deslandre, Fernanda Falcini, Maria Alessio, Francesco La Torre, Ekaterina Denisova, Giorgia Martini, Irina Nikishina, Francesco Zulian
The Journal of Rheumatology Nov 2016, 43 (11) 2068-2073; DOI: 10.3899/jrheum.151389